{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:38:42Z","timestamp":1790908722058,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Prof Paola Rapelli for donating the Caco-2 cells"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.colsurfb.2017.01.031","type":"journal-article","created":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T05:46:16Z","timestamp":1484804776000},"page":"296-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":229,"special_numbering":"C","title":["Nose-to-brain delivery of BACE1 siRNA loaded in solid lipid nanoparticles for Alzheimer\u2019s therapy"],"prefix":"10.1016","volume":"152","author":[{"given":"Giovanna","family":"Rassu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Soddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Posadino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Pintus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Sarmento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Giunchedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Gavini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2017.01.031_bib0005","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijpharm.2009.06.019","article-title":"Nanoparticles for direct nose-to-brain delivery of drugs","volume":"379","author":"Mistry","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0010","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","article-title":"Intranasal delivery of biologics to the central nervous system","volume":"64","author":"Lochhead","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0015","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1517\/17425247.2013.790887","article-title":"Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood\u2013brain barrier: an excellent platform for brain targeting","volume":"10","author":"Pardeshi","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0020","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4155\/tde.14.41","article-title":"The nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overview","volume":"5","author":"Djupesland","year":"2014","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jddst.2015.05.002","article-title":"Particulate formulations based on chitosan for nose-to-brain delivery of drugs. A review","volume":"32","author":"Rassu","year":"2016","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","article-title":"Nasal drug delivery-possibilities, problems and solutions","volume":"87","author":"Illum","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0035","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1021\/acs.molpharmaceut.5b00088","article-title":"Nose-to-brain delivery: investigation of the transport of nanoparticles with different surface characteristics and sizes in excised porcine olfactory epithelium","volume":"12","author":"Mistry","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0040","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/10611860802556842","article-title":"Mucoadhesive microspheres for nasal administration of cyclodextrins","volume":"17","author":"Gavini","year":"2009","journal-title":"J. Drug Target."},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0045","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/jps.22382","article-title":"Influence of chitosan glutamate on the in vivo intranasal absorption of rokitamycin from microspheres","volume":"100","author":"Gavini","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1166\/jns.2012.1015","article-title":"Mucoadhesive drug delivery systems for nose-to-brain targeting of dopamine","volume":"2","author":"Gavini","year":"2012","journal-title":"J. Nanoneurosci."},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0055","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejpb.2012.10.010","article-title":"Influence of polymeric microcarriers on the in vivo intranasal uptake of an anti-migraine drug for brain targeting","volume":"83","author":"Gavini","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0060","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.antiviral.2015.09.013","article-title":"Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries","volume":"123","author":"Dalpiaz","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0065","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2015.01.025","article-title":"Solid microparticles based on chitosan or methyl-\u03b2-cyclodextrin: a first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate","volume":"201","author":"Rassu","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0070","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.xphs.2016.05.017","article-title":"Neuroprotective effects of engineered polymeric nasal microspheres containing hydroxypropyl-\u03b2-cyclodextrin on \u03b2-Amyloid (1\u201342)\u2013induced toxicity","volume":"105","author":"Yalcin","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0075","first-page":"285","article-title":"Gene knockdown in the olfactory bulb, amygdala, and hypothalamus by intranasal siRNA administration","volume":"42","author":"Kim","year":"2009","journal-title":"Korean J. Anat."},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0080","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neulet.2012.02.037","article-title":"Intranasal delivery of siRNA to the olfactory bulbs of mice via the olfactory nerve pathway","volume":"513","author":"Renner","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0085","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1016\/j.biomaterials.2013.08.036","article-title":"Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles","volume":"34","author":"Kanazawa","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0090","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1021\/mp400644e","article-title":"Prolongation of life in rats with malignant glioma by intranasal siRNA\/drug codelivery to the brain with cell-penetrating peptide-modified micelles","volume":"11","author":"Kanazawa","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0095","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.nano.2016.01.002","article-title":"Robust neuroprotective effects of intranasally delivered iNOS siRNA encapsulated in gelatin nanoparticles in the post ischemic brain","volume":"12","author":"Kim","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0100","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.2174\/138955707782331678","article-title":"RNA interference as a tool for Alzheimer\u2019s disease therapy","volume":"7","author":"Orlacchio","year":"2007","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0105","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ymthe.2006.01.001","article-title":"Progress towards in vivo use of siRNAs","volume":"13","author":"Behlke","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0110","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00018-009-0186-0","article-title":"Cell penetrating peptides: overview and applications to the delivery of oligonucleotides","volume":"67","author":"Said Hassane","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0115","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.apsb.2016.04.001","article-title":"Nose-to-brain delivery of macromolecules mediated by cell-penetrating peptides","volume":"6","author":"Lin","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0120","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.nano.2015.12.374","article-title":"Intranasal brain delivery of cationic nanoemulsion-encapsulated TNF\u03b1 siRNA in prevention of experimental neuroinflammation","volume":"12","author":"Yadav","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0125","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/1570159X11311020006","article-title":"Cell-penetrating peptide-mediated therapeutic molecule delivery into the central nervous system","volume":"11","author":"Zou","year":"2013","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejps.2015.04.005","article-title":"From naturally-occurring neurotoxic agents to CNS shuttles for drug delivery","volume":"74","author":"Soddu","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/chemse\/25.1.61","article-title":"Evidence for nicotinic acetylcholine receptors on nasal trigeminal nerve endings of the rat","volume":"25","author":"Alimohammadi","year":"2000","journal-title":"Chem. Senses"},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0140","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/wnan.1233","article-title":"Bioengineered nanoparticles for siRNA delivery","volume":"5","author":"Kozielski","year":"2013","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0145","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1016\/j.febslet.2006.10.076","article-title":"Altered \u03b2-secretase enzyme kinetics and levels of both BACE1 and BACE2 in the Alzheimer\u2019s disease brain","volume":"580","author":"Stockley","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0150","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0927-7765(02)00053-X","article-title":"Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules","volume":"27","author":"Fuentes","year":"2003","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0155","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijpharm.2006.07.026","article-title":"Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin","volume":"327","author":"Zhang","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0160","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ijpharm.2013.08.076","article-title":"Effect of freeze-drying, cryoprotectants and storage conditions on the stability of secondary structure of insulin-loaded solid lipid nanoparticles","volume":"456","author":"Soares","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0165","doi-asserted-by":"crossref","first-page":"9199","DOI":"10.1016\/j.biomaterials.2014.07.026","article-title":"The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium","volume":"35","author":"Ara\u00fajo","year":"2014","journal-title":"Biomaterials"},{"issue":"Jan\u2013Feb (1)","key":"10.1016\/j.colsurfb.2017.01.031_bib0170","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/10717540490280345","article-title":"Transepithelial electrical resistance is not a reliable measurement of the Caco-2 monolayer integrity in Transwell","volume":"11","author":"Mukherjee","year":"2004","journal-title":"Drug Deliv."},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0175","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature05901","article-title":"Transvascular delivery of small interfering RNA to the central nervous system","volume":"448","author":"Kumar","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0180","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jconrel.2014.05.003","article-title":"Chitosan in nasal delivery systems for therapeutic drugs","volume":"190","author":"Casettari","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0185","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00396-010-2341-4","article-title":"The temperature effect on electro kinetic properties of the silica\u2013polyvinyl alcohol (PVA) system","volume":"289","author":"Wi\u015bniewska","year":"2011","journal-title":"Colloid. Polym. Sci."},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0190","first-page":"17","article-title":"Formulation and optimization of solid lipid nanoparticle formulation for pulmonary delivery of budesonide using Taguchi and Box-Behnken design","volume":"10","author":"Emami","year":"2015","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0195","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/cne.902940212","article-title":"Ultrastructure of substance P-and CGRP immunoreactive nerve fibers in the nasal epithelium of rodents","volume":"294","author":"Finger","year":"1990","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0200","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery\u2212a review of the state of the art","volume":"50","author":"M\u00fcller","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2017.01.031_bib0205","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijpharm.2015.12.046","article-title":"Nanoparticle transport across in vitro olfactory cell monolayers","volume":"499","author":"Gartziandia","year":"2016","journal-title":"Int. J. Pharm."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776517300401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776517300401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T14:03:32Z","timestamp":1582553012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776517300401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":41,"alternative-id":["S0927776517300401"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2017.01.031","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nose-to-brain delivery of BACE1 siRNA loaded in solid lipid nanoparticles for Alzheimer\u2019s therapy","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2017.01.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}